Splenic irradiation in the management of Waldenstrom macroglobulinemia

Leukemia and Lymphoma

Volumn 50, Issue 6, 2009, Pages 1047-1049

  Davda, Reena ^a   Davies, Sian ^a   Kumaran, Thuraisamy ^a  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRRADIATION; LEUKOCYTE COUNT; PANCYTOPENIA; PLASMA VISCOSITY; PLASMAPHERESIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SPLEEN RADIATION; SPLENOMEGALY; THROMBOCYTE COUNT; VISUAL DISORDER; WALDENSTROEM MACROGLOBULINEMIA;

FEMALE; HUMANS; MIDDLE AGED; SPLEEN; SPLENOMEGALY; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 68449094988     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902898263     Document Type: Article

References (14)

1. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30:100-115.
2. Dimopoulos M, Gertz M, Kastritis E, Garcia-Sanz R, Kimby E, LeBlond V, et al. Update on treatment recommendations from the fourth international workshop on Waldenström's macroglobulinemia. J Clin Oncol 2009;27: 120-126.
3. Treon SP, Gertz MA, Dimopoulos M, Anagnostopoulos A, Blade J, Branagan AR, et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. Blood 2006;107: 3442-3446.
4. Bristow R, Hill R. Molecular and cellular basis of radiotherapy. In: Tannock I, Hill R, Bristow R, Harrington L, editors. The basic science of oncology. New York, USA: McGraw-Hill Medical Publishing Divsion; 2005. pp 261-289.
5. Mole RJ. Whole body irradiation-radiology or medicine? Br J Radiol 1953;26:234-241.
6. Byhardt RW, Brace KC, Wiernik PH. The role of splenic irradiation in chronic lymphocytic leukemia. Cancer 1975;35: 1621-1625.
7. Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol 1975 48:863-866.
8. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998;43: 575-577.
9. Delic J, Magdelenat H, Barbaroux C, Chaillet MP, Dubray B, Gluckman E, et al. In-vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol 1995;68:997-1003.
10. Camphausen K, Moses M, Menard C, Sproull M, Beecken W, Folkman, O'Reilly M. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 2003;63:1990-1993.
11. Macklis RM, Mauch PM, Burakoff SJ, Smith BR. Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodkin's disease. Cancer 1992; 778-783.
12. Filippi AR, Franco P, Galliano M, Ricardi U. Peripheral blood complete remission after splenic irradiation in mantlecell lymphoma with 11q22-23 deletion and ATM inactivation. Radiat Oncol 2006;1:35.
13. Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol 2001;58:235-246.
14. Jyothirmayi R, Coltarty S. An audit of the indications for and techniques of palliative splenic radiotherapy in the UK. Clin Oncol 2005;17:192-194.